ROBERT ALAN FIGLIN, MD
Osteopathic Medicine in Duarte, CA
License number
California G35300
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
2
1500 E. Duarte Rd., Duarte, CA 91010
File #55737, Los Angeles, CA 90074
File #55737, Los Angeles, CA 90074
Phone
(626) 359-8111
(310) 301-8708
(310) 301-8751 (Fax)
(310) 301-8708
(310) 301-8751 (Fax)
Professional information
Dr. Robert A Figlin, West Hollywood CA - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
8700 Beverly Blvd STE AC10, West Hollywood 90048
(310) 423-8030 (Phone)
(310) 423-8030 (Phone)
Certifications:
Internal Medicine, 1979, Medical Oncology, 1983
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
8700 Beverly Blvd STE AC10, West Hollywood 90048
Cedars - Sinai Medical Center
8700 West Beverly Blvd, West Hollywood 90048
Cedars - Sinai Medical Center
8700 West Beverly Blvd, West Hollywood 90048
Education:
Medical School
Medical College Of Pennsylvania
Graduated: 1976
Cedars Sinai Med Center
Graduated: 1977
Graduated: 1980
UCLA Center Health Science
Graduated: 1982
Medical College Of Pennsylvania
Graduated: 1976
Cedars Sinai Med Center
Graduated: 1977
Graduated: 1980
UCLA Center Health Science
Graduated: 1982
Division Director At Cedars-Sinai Medical Center
Position:
Division Director at Cedars-Sinai Medical Center
Location:
Greater Los Angeles Area
Industry:
Hospital & Health Care
Work:
Cedars-Sinai Medical Center
-
Division Director
Robert A Figlin, Duarte CA
Specialties:
Internal Medicine, Medical Oncology, Hematology & Oncology
Work:
Med Oncology & Therapeutics Research
1500 Duarte Rd, Duarte, CA 91010 Cedars-Sinai Medical Center
8700 Beverly Blvd, Los Angeles, CA 90048
1500 Duarte Rd, Duarte, CA 91010 Cedars-Sinai Medical Center
8700 Beverly Blvd, Los Angeles, CA 90048
Education:
Drexel University(1976)
Methods For Enhancing Antigen-Presenting Cells And Anti-Tumor Responses In A Human Patient
US Patent:
6838081, Jan 4, 2005
Filed:
Apr 2, 1999
Appl. No.:
09/647248
Inventors:
Michael Derek Roth - Los Angeles CA, US
Robert Alan Figlin - Los Angeles CA, US
Sylvia Marie Kiertscher - Los Angeles CA, US
Barbara Jennifer Gitlitz - Los Angeles CA, US
Robert Alan Figlin - Los Angeles CA, US
Sylvia Marie Kiertscher - Los Angeles CA, US
Barbara Jennifer Gitlitz - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A01N 6300, A61K 4500, A61K 3819, C12N 501, C12N 508
US Classification:
424 937, 424 9371, 424 852, 424 857, 435372, 435355, 435366, 435374, 435377, 435384, 435386, 435423
Abstract:
The present invention provides methods for enhancing the development of APC from precursor cells by administering a combination of GM-CSF and IL-4. The precursor cells include: cells contained in peripheral blood, CD cells and precursors in bone marrow. Thus, administration of GM-CSF and IL-4 can be used as a form of cytokine immunotherapy. One embodiment of the present invention involves systemic administration of GM-CSF and IL-4. In this embodiment, APC are required to directly access tumor antigens as they exist in vivo within the patient. A further embodiment of the present invention involves co-administration of a tumor-associated or tumor-specific antigen, with GM-CSF and IL-4, to induce antigen-specific immunity mediated by APC. Yet another embodiment of the present invention describes systemic administration of GM-CSF and IL-4 to achieve reduced tumor burden.